UBS Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9K | Buy |
12,380
+12,127
| +4,793% | +$13.6K | ﹤0.01% | 7366 |
|
|
2025
Q1 | $319 | Sell |
253
-3,219
| -93% | -$4.06K | ﹤0.01% | 8506 |
|
|
2024
Q4 | $7.88K | Buy |
3,472
+3,305
| +1,979% | +$7.5K | ﹤0.01% | 7206 |
|
|
2024
Q3 | $575 | Sell |
167
-307
| -65% | -$1.06K | ﹤0.01% | 7664 |
|
|
2024
Q2 | $2.41K | Buy |
474
+307
| +184% | +$1.56K | ﹤0.01% | 7201 |
|
|
2024
Q1 | $1.41K | Hold |
167
| – | – | ﹤0.01% | 6966 |
|
|
2023
Q4 | $683 | Sell |
167
-76
| -31% | -$311 | ﹤0.01% | 7334 |
|
|
2023
Q3 | $728 | Buy |
243
+76
| +46% | +$228 | ﹤0.01% | 7162 |
|
|
2023
Q2 | $5.15K | Sell |
167
-333
| -67% | -$10.3K | ﹤0.01% | 6389 |
|
|
2023
Q1 | $24.8K | Hold |
500
| – | – | ﹤0.01% | 5833 |
|
|
2022
Q4 | $12.3K | Hold |
500
| – | – | ﹤0.01% | 7098 |
|
|
2022
Q3 | $33K | Sell |
500
-20
| -4% | -$1.32K | ﹤0.01% | 5671 |
|
|
2022
Q2 | $22K | Buy |
520
+6
| +1% | +$254 | ﹤0.01% | 5710 |
|
|
2022
Q1 | $26K | Sell |
514
-446
| -46% | -$22.6K | ﹤0.01% | 6095 |
|
|
2021
Q4 | $58K | Buy |
960
+226
| +31% | +$13.7K | ﹤0.01% | 5670 |
|
|
2021
Q3 | $37K | Sell |
734
-200
| -21% | -$10.1K | ﹤0.01% | 5448 |
|
|
2021
Q2 | $54K | Sell |
934
-153
| -14% | -$8.85K | ﹤0.01% | 5291 |
|
|
2021
Q1 | $63K | Buy |
1,087
+332
| +44% | +$19.2K | ﹤0.01% | 5325 |
|
|
2020
Q4 | $51K | Buy |
755
+188
| +33% | +$12.7K | ﹤0.01% | 5165 |
|
|
2020
Q3 | $144K | Sell |
567
-563
| -50% | -$143K | ﹤0.01% | 4157 |
|
|
2020
Q2 | $190K | Buy |
1,130
+963
| +577% | +$162K | ﹤0.01% | 4038 |
|
|
2020
Q1 | $12K | Hold |
167
| – | – | ﹤0.01% | 5899 |
|
|
2019
Q4 | $11K | Hold |
167
| – | – | ﹤0.01% | 6151 |
|
|
2019
Q3 | $10K | Sell |
167
-171
| -51% | -$10.2K | ﹤0.01% | 6183 |
|
|
2019
Q2 | $20K | Buy |
+338
| New | +$20K | ﹤0.01% | 5729 |
|
|
2019
Q1 | – | Sell |
-130
| Closed | -$7K | – | 6856 |
|
|
2018
Q4 | $7K | Buy |
130
+95
| +271% | +$5.12K | ﹤0.01% | 6469 |
|
|
2018
Q3 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 6796 |
|
|
2018
Q2 | – | Sell |
-103
| Closed | -$5K | – | 7014 |
|
|
2018
Q1 | $5K | Sell |
103
-24
| -19% | -$1.17K | ﹤0.01% | 6324 |
|
|
2017
Q4 | $7K | Sell |
127
-143
| -53% | -$7.88K | ﹤0.01% | 6238 |
|
|
2017
Q3 | $17K | Buy |
270
+122
| +82% | +$7.68K | ﹤0.01% | 5659 |
|
|
2017
Q2 | $9K | Sell |
148
-240
| -62% | -$14.6K | ﹤0.01% | 5883 |
|
|
2017
Q1 | $25K | Buy |
388
+328
| +547% | +$21.1K | ﹤0.01% | 5069 |
|
|
2016
Q4 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 6499 |
|
|
2016
Q3 | – | Sell |
-359
| Closed | -$13K | – | 6692 |
|
|
2016
Q2 | $13K | Buy |
+359
| New | +$13K | ﹤0.01% | 5723 |
|
|
2016
Q1 | – | Sell |
-68
| Closed | -$3K | – | 6692 |
|
|
2015
Q4 | $3K | Hold |
68
| – | – | ﹤0.01% | 6463 |
|
|
2015
Q3 | $2K | Hold |
68
| – | – | ﹤0.01% | 6566 |
|
|
2015
Q2 | $4K | Sell |
68
-212
| -76% | -$12.5K | ﹤0.01% | 6352 |
|
|
2015
Q1 | $19K | Buy |
280
+236
| +536% | +$16K | ﹤0.01% | 5407 |
|
|
2014
Q4 | $3K | Buy |
+44
| New | +$3K | ﹤0.01% | 6486 |
|